Simulation-Based Virtual Reality (VR) Visualization of Cerebral Aneurysms Treated with Stents

基于模拟的虚拟现实 (VR) 支架治疗脑动脉瘤可视化

• 批准号: 538407-2019
• 负责人: Chen, Xiongbiao
• 金额: $ 1.82万
• 依托单位: University of Saskatchewan
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=681139
• 关键词: Simulation; Based; Virtual; Reality; VR

A cerebral aneurysm (or brain aneurysm) is an abnormal blood-filled bulge in a blood vessel. If untreated, a cerebral aneurysm presents a high risk of rupture, and may lead to haemorrhagic stroke - a leading cause of disability and death in Canada. Flow-diverting stents (small mesh tubes inserted into the artery) show considerable promise for the treatment of cerebral aneurysms by lowering rupture risk. Despite encouraging results of treatment with such stents, post-treatment complications have been reported at rates of 15-35%. The project aims to develop a novel way to visualize the stent-treatment outcomes based on virtual reality (VR) technology, which allows one to see the stent-treatment outcomes very much like 3D movies. The success of this project will help neurosurgeons discern the factors that might contribute to the success/failure of previously treated patients and to predict and strategically plan stent treatment or re-treatment for aneurysm patients. It will also greatly facilitate/enhance the immersive learning/understanding of aneurysm treatment with stents for medical students/residents and aneurysm patients. The successful completion of our objectives will mean LUXSONIC Technologies Inc. of Saskatoon, SK (https://www.luxsonic.ca/; hereafter LUXSONIC), the industrial partner of this project, will reap immediate technological and economic benefits because the project will help to launch a new VR-based product for medical education/training and health care.

脑动脉瘤(或脑动脉瘤)是血管中异常的充满血液的突起。如果不治疗，脑动脉瘤破裂的风险很高，并可能导致出血性中风--在加拿大，这是导致残疾和死亡的主要原因。分流支架(插入动脉的小网状管)通过降低破裂风险，在治疗脑动脉瘤方面显示出相当大的前景。尽管这种支架的治疗结果令人鼓舞，但据报道，治疗后并发症的发生率为15%-35%。该项目旨在开发一种基于虚拟现实(VR)技术的可视化支架治疗结果的新方法，使人们能够像3D电影一样查看支架治疗结果。该项目的成功将有助于神经外科医生识别可能导致先前治疗患者成功/失败的因素，并预测和战略性地计划对动脉瘤患者进行支架治疗或再次治疗。它还将极大地促进/提高医学生/住院医生和动脉瘤患者对支架治疗动脉瘤的沉浸式学习/理解。我们的目标的成功完成将意味着该项目的工业合作伙伴、SK萨斯卡通的卢克森科技公司(以下简称https://www.luxsonic.ca/；)将立即获得技术和经济效益，因为该项目将有助于推出一种新的基于VR的医疗教育/培训和医疗保健产品。